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Abstract: Stem cells genome safeguarding requires strict oxidative stress control. Heme oxygenase-
1 (HO-1) and p53 are relevant components of the cellular defense system. p53 controls cellular
response to multiple types of harmful stimulus, including oxidative stress. Otherwise, besides
having a protective role, HO-1 is also involved in embryo development and in embryonic stem
(ES) cells differentiation. Although both proteins have been extensively studied, little is known
about their relationship in stem cells. The aim of this work is to explore HO-1-p53 interplay in ES
cells. We studied HO-1 expression in p53 knockout (KO) ES cells and we found that they have
higher HO-1 protein levels but similar HO-1 mRNA levels than the wild type (WT) ES cell line.
Furthermore, cycloheximide treatment increased HO-1 abundance in p53 KO cells suggesting that
p53 modulates HO-1 protein stability. Notably, H2O2 treatment did not induce HO-1 expression in
p53 KO ES cells. Finally, SOD2 protein levels are also increased while Sod2 transcripts are not in
KO cells, further suggesting that the p53 null phenotype is associated with a reinforcement of the
antioxidant machinery. Our results demonstrate the existence of a connection between p53 and HO-1
in ES cells, highlighting the relationship between these stress defense pathways.
Keywords: heme oxygenase-1; p53; embryonic stem cells; gene expression regulation
1. Introduction
Diverse hostile conditions perturb cell homeostasis, inducing cellular stress that
consequently results in gene expression alterations and damage to DNA, RNA, proteins
and lipids [1]. Stress stimuli come from both external and internal sources. Extrinsic stress
is usually determined by environmental factors that cause tissue and cellular damage.
On the other hand, intrinsic types of stress are generated by normal metabolism which
produces an accumulation of residual products and reactive metabolites [2]. Such is the
case of oxidative stress promoted by multiple stimuli including reactive oxygen species
(ROS), products of physiological cell activity originated in many cellular compartments.
Although low to moderate levels of ROS are required for various cellular processes such as
signal transduction, proliferation, apoptosis and differentiation [3–5], the accumulation
of ROS has harmful effects on cell homeostasis and on diverse cellular structures and
functions. Of note, excessive ROS production is associated with diverse human diseases,
inflammation, and aging [6].
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Embryonic stem (ES) cells are pluripotent cells that have the ability to differentiate
into all the adult cell lineages, and are also characterized by an unlimited replication
potential [7,8]. Stress mitigation is crucial in pluripotent stem cells due to their essential
role in development and the risk associated with malignant transformation. In addition,
multiple pathways related to stress response and repair are upregulated in these cells,
therefore ensuring their genomic stability [2,9,10].
Particularly, pluripotent stem cells harbor lower ROS levels due to their exacerbated
antioxidant mechanisms characterized by gene induction and activation of multiple detoxi-
fying enzymes [11]. However, fine-tuned ROS levels are involved in signaling pathways
promoting, for example, specific differentiation processes. Therefore, intracellular redox
status regulates the balance between self-renewal and differentiation [12–16]. Consequently,
oxidative stress control is highly relevant for self-renewal and pluripotency maintenance
of pluripotent stem cells [17].
The transcription factor (TF) and tumor suppressor p53 plays a vital role in the cell by
controlling cellular response to multiple types of harmful stimulus, including oxidative
stress. Under transient and mild oxidative stress conditions, p53 holds an antioxidant
function and contributes to maintain low ROS levels; however, under severe stress, p53
has pro-oxidant actions [18]. The main mechanisms by which this protein exerts its actions
include inhibition of cell proliferation, induction of cell differentiation, modulation of
metabolism, and the onset of apoptosis or cellular senescence [19]. Regarding ROS modula-
tion by p53 in the context of stem cells and development, it was reported that p53 fine-tunes
endogenous ROS levels to ensure the proper prenatal neurogenesis [20]. Additionally, p53
maintains the pool of hematopoietic stem cells by reducing ROS levels [21]. In pluripotent
stem cells, p53 activates the expression of antioxidant genes, thus reducing the levels of
oxidative stress and contributing to genomic stability [22]. Particularly, the primary role of
p53 in ES cells is to promote differentiation in response to DNA damage or developmental
signals [23]. For instance, p53 represses the expression of Nanog, a key pluripotency TF,
thus inducing ES cells to differentiate into cell types that can efficiently execute cell death
programs [24]. On the other hand, it has also been demonstrated that p53 is required for ES
cells self-renewal [25]. This apparently contradictory evidence highlights the complexity of
p53 function in ES cells.
A highly relevant component of the antioxidant system is heme oxygenase-1 (HO-1),
encoded by Hmox1 gene, an integral protein of the endoplasmic reticulum (ER) that exhibits
cytoprotective and anti-inflammatory functions [26]. In addition to HO-1 cytoprotective
ability, this protein is also involved in embryo development and stem cells differentia-
tion [27]. Interestingly, Hmox1 contains p53 response elements [28] and this TF promotes
cell survival by Hmox1 induction under oxidative stress conditions [29]. The main TF that
promotes Hmox1 expression is the nuclear factor erythroid 2-related factor 2 (NRF2), that
coordinates the basal and stress-induced activation of several cytoprotective genes, control-
ling key components of the cellular antioxidant system [30]. Both NRF2 and p53 regulate
the expression of proteins involved in the protection against oxidative stress, and it has
been suggested that there is a crosstalk between them [31,32], even though this interplay is
not completely understood. Moreover, a link between p53 and NRF2 was described in mul-
tiple tumorigenic scenarios like lung and breast cancer [33,34]. Furthermore, NRF2 deficits
are buffered by compensatory increases in p53 signaling, and striking ROS-dependent
phenotypes arise when both pathways are perturbed in breast-mammary epithelia [32]. In
the context of stem cells, NRF2 overexpression protects mesenchymal stem cells against
cell death caused by oxidative stress and preserves multi-differentiation potential [35].
Moreover, NRF2 plays a crucial role in the maintenance of mesenchymal stem cells proper-
ties through p53–SIRT1 axis regulation [36]. Remarkably, NRF2 controls the self-renewal
and pluripotency of human ES cells and is required for pluripotency reestablishment dur-
ing induced pluripotent stem (iPS) cells generation [13]. Furthermore, it was found that
HO-1 modulation affects both, the cellular reprograming efficiency and the capability of
pluripotent stem cells to spontaneously differentiate to cardiac lineages [37]. Interestingly,
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it was suggested that HO-1 function during fibroblasts reprograming could be related
to p53 downregulation [37]. This evidence highlights the existence of an interesting and
complex connection between p53 and HO-1 in pluripotent stem cells that has not been fully
described yet.
In this work, we found that p53 knockout (KO) ES cells have higher HO-1 protein
levels compared to the wild type (WT) cell line. Our results suggest the existence of a
p53-dependent negative modulation of HO-1 protein stability and that p53 null phenotype
is related with an altered ROS homeostasis in ES cells, associated with a reinforcement
of the antioxidant machinery at the post-translational level. Furthermore, we found that
HO-1 increases during differentiation in both WT and KO ES cells, suggesting a possible
connection between HO-1 and the exit of the pluripotent state or differentiation progression.
As a whole, our results evidence a regulatory crosstalk between these two stress pathways
in ES cells.
2. Materials and Methods
2.1. Cell Culture and Treatments
The W4 ES cell line was provided by the Rockefeller University Core Facility and W4
p53 KO ES cell line was previously generated by CRISPR/Cas9 technology in our lab [38].
Cells were routinely cultured in 2i/LIF ES medium consisting of DMEM, Glutamax (2 mM),
MEM NEAA (100 mM), 2-mercaptoethanol (0.1 mM), penicillin (100 U/mL), streptomycin
(100 mg/mL) and FBS (15%, Gibco, Paisley, UK), LIF, PD0325901 (1 µM, Tocris, Bristol, UK)
and CHIR 99,021 (3 µM, Tocris). Cells were plated on bovine gelatin (0.1%, Sigma, St. Louis,
MO, USA) coated dishes at 37 ◦C in a 5% CO2 (v/v) incubator and passaged every three
days. To induce HO-1 expression, cells were pre-treated or treated with hemin (20 µM,
Sigma) during 20 h. Cell viability and proliferation were evaluated using MTT (Sigma) and
Crystal Violet. To inhibit protein synthesis cells were treated with cycloheximide (10 µM,
Sigma) during 2 or 7 h. To induce differentiation cells were cultured in the absence of LIF
and 2i for 48 h. To evaluate the effect of H2O2 on HO-1 induction cells were exposed to
H2O2 (100 µM) during 4 h.
2.2. Gene Expression Analysis
Gene expression was analyzed by reverse transcription real-time quantitative PCR (RT-
qPCR), immunofluorescence (IF) and/or Western blot (WB) as previously described [39],
using the following primers and antibodies: primers: Gapdh (Forward TGCCAAGGCT-
GTGGGCAAGG, Reverse CGAAGGTGGAAGAGTGGG), Hmox1 (Forward AAGAGGC-
TAAGACCGCCTTC, Reverse GCATAAATTCCCACTGCCAC) and Sod2 (Forward AAG-
CACCACGCGGCCTACG, Reverse CCATTGAACTTCAGTGCAGGCTG); antibodies: anti-
HO-1 (Abcam, Cambridge, UK, ab 13248), anti-NRF2 (Santa Cruz, Minneapolis, MN,
USA, SC-722), anti-pS40 NRF2 (Abcam, ab76026), anti-SOD2 (Santa Cruz, sc-137254), anti-
GAPDH (Santa Cruz, SC-32233), anti-mouse AlexaFluor 555 (Invitrogen, Waltham, MA,
USA, A31570), anti-mouse IgG-HRP (Invitrogen, G-21040).
2.3. Complementation Assay
W4 p53 KO ES cells were seeded on gelatin-coated coverslips in 24-well plates and
transfected with 300 ng of p53-GFP expression vector (kindly provided by Dr. Martin
Monte, IQUIBICEN/Universidad de Buenos Aires). Transfection was carried out as previ-
ously described [40]. 48 h after transfection, HO-1 was visualized by immunofluorescence
and nuclei were counterstained with DAPI. Transfected cells were identified by GFP
fluorescence detection.
2.4. Nuclear-Cytoplasmic Ratio Estimation
HO-1 immunofluorescence (IF) images were acquired in a wide-field Olympus IX71
microscope equipped with an EXi Aqua Bio-Imaging Microscopy Camera (Qimaging,
Surrey, BC, Canada). The mean intensity of HO-1 staining in nuclei and cytoplasm was
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measured in wide-field images since it was easier to delimit the cytoplasmic region of
single cells in comparison to confocal images. Nuclei were identified by DAPI staining
and a cytoplasm mask was constructed by thresholding the images obtained in the HO-1
channel and subtracting the region corresponding to nuclei. Nuclei vs. cytoplasm mean
intensity was fitted with a linear equation weighted by the number of cells on each field.
2.5. Bioinformatics Analysis
The Stemformatics web tool [41] was used to evaluate HMOX1 and TP53 gene expres-
sions in different human pluripotent stem cell lines subjected to both non-directed and
directed differentiation protocols and in human somatic cells subjected to reprograming
(Table 1).
Table 1. Expression microarray and RNA-seq studies selected from the Stemformatics platform (https://www.stemformatics.
org./). N/A = not available.
Reference Cell Line Platform Accession No
Non-directed diff Enver et al., 2005 [42] H7 Affymetrix U133A N/A
Reprograming Kyrkou et al., 2016 [43] Fibroblast and iPS cells Affymetrix HuGene-1_0-ST V1 GSE58932
Embryo development Yi et al., 2010 [44] Human embryos Affymetrix HG-U133_Plus_2 GSE15744
Ectodermal diff Pandya et al., 2017 [45] iPS cells and iPS derivedmicroglia Affymetrix MoGene-1_0-ST V1 GSE47605
Ectodermal diff Mariani et al., 2015 [46] iPS cells Illumina HiSeq 2000 GSE61476
Mesodermal diff An et al., 2014 [47] Erythroblasts Illumina HiSeq 2000 GSE53983
Mesodermal diff Granchi et al., 2010 [48] Mesenchymal stem cells Affymetrix HG-U133_Plus_2 GSE12267
Endodermal diff Si-Tayeb et al., 2010 [49] iPS cells Affymetrix HG-U133_Plus_2 GSE14897
Endodermal diff Teo et al., 2011 [50] ES cells Illumina HumanRef-8 V3 E-MTAB-467
2.6. Flow Cytometry
ES cells were plated in a 6-well plate (120,000 cells/well) using ES cell medium. 24 h
after cells were trypsinized, resuspended with PBS and incubated with 6 µM 5,6-clorometil-
2′7′-dichloro dihydro-fluorescein diacetate, acetyl ester (CM-H2DCFDA; Invitrogen) for 1 h
at 37C. H2DCFDA levels were measured by flow cytometry and analyzed with the FlowJo
7.6 software. Experiments with NpFR1 and NpFR2 probes were performed as previously
described [51,52].
2.7. Statistical Analysis
Experimental results are presented as mean ± standard error of the mean (SEM).
Statistical comparisons were performed using Student´s t-Test or randomized block design
ANOVA followed by a Tukey post-test for at least three biological replicates using Infostat
or GraphPad Prism softwares. In all cases, residuals fitted normal distribution, assessed by
Shapiro-Wilks test, and homogeneity of variance, using Levene test. p values < 0.05 were
considered significant.
3. Results
3.1. HO-1 Protein Levels Are Boosted in p53 Knockout ES Cells
Based on the role of p53 in the cellular defense system and the relationship between
p53 and NRF2 mentioned above, we decided to focus our study on the protein HO-1,
one of the most relevant targets of NRF2, which is involved in stem cells differentiation
and reprograming. To explore p53 and HO-1 interplay in ES cells, we first compared
HO-1 protein levels between a p53 null ES cell line and the corresponding WT parental ES
cell line. The p53 KO ES cell line was previously generated in our lab by CRISPR/Cas9
technology. It is homozygous for an insertion of a single nucleotide, which induced a
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frameshift starting on amino acid 17 and a non-sense mutation on exon 4. This cell line
displays normal morphology, cell-cycle distribution and similar expression of pluripotency
markers compared to the parental cell line [38]. Notably, the analysis of HO-1 protein
levels by WB and IF showed higher HO-1 expression in p53 KO ES cells compared to WT
(Figure 1a,b). To restore p53 expression in p53 KO ES cells, we performed a complementa-
tion assay and we observed that p53-GFP transfected cells displayed lower HO-1 protein
levels than non-transfected cells within the same field (Supplementary Figure S1), strongly
suggesting that p53 modulates HO-1 levels and further supporting our results.
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Figure 1. HO-1 protein levels are boosted in p53 knockout ES cells. WT and p53 KO ES cells were
cultured under standard conditions. (a) HO-1 protein levels were analyzed by Western blot, upper
panels show representative blots. GAPDH was used as the loading control. Lower panels show
HO-1/GAPDH band densitometry relative to WT ES cells. Bars represent the mean ± SEM of three
independent experiments. Asterisks indicate significant differences between cell lines (*, p < 0.05).
(b) HO-1 levels were analyzed by Immunofluorescence. Representative confocal images of ES cell
colonies are shown. The green pseudocolor represents HO-1 specific immunostaining, scale bars:
10 µm.
To explore whether NRF2 mediates the exacerbation of HO-1 expression in p53 KO ES
cells, we analyzed its status in our experimental system. We found no significant differences
between p53 KO and WT ES cells in both total NRF2 and NRF2 phosphorylated at Ser
40 (pS40 NRF2), a post-translational modification (PTM) associated with the activation of
this TF [53] (Figure 2a). These results suggest that the differences found in HO-1 levels
between these cell lines are not regulated at the transcriptional level. In agreement, no
significant changes in HO-1 mRNA levels were observed in p53 KO and WT ES cell
lines (Figure 2b), supporting that these boosted HO-1 levels are not due to differential
transcriptional regulation and suggesting that a post-transcriptional mechanism might be
involved. We hypothesize that the higher HO-1 protein levels found in p53 KO ES cells
could probably be due to a cellular strategy to mitigate the stress generated by the lack of
p53, in order to restore homeostasis and maintain cellular wellness.
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Figure 2. Increased HO-1 expression is not regulated at the transcriptional level. WT and p53 KO ES cells were cultured un-
der standard conditions. (a) NRF2 and pS40 NRF2 levels were analyzed by Western blot. Upper panels show representative
blots. GAPDH was used as loading control. Lower panels show NRF2 and pS40 NRF2/GAPDH ban densitometry relative
to WT ES cells. Bars represent the mean ± SEM of three independent experiments. (b) HO-1 mRNA levels were analyzed
by RT-qPCR, normalized to the housekeeping gene Gapdh and referred to WT ES cells. Bars represent the mean ± SEM of
three independent experiments. Non-significant (ns) differences between cell lines were observed.
3.2. HO-1 Half-Life Is Longer in p53 KO ES Cells
To explore whether higher HO-1 levels in p53 KO ES cells were a consequence of a
differ ntial post-transcriptional regulation in this cell line, we studied HO-1 half-life. We
treated WT and KO ES cells with the commonly used protein synthesis inhibitor cyclohex-
imide (CHX) during 2 or 7 h and evaluated HO-1 pro ein levels by WB. Interestingly, we
found that HO-1 protein levels were less sensitive to CHX treatmen in p53 KO ES cells
than in WT (Figur 3a), sugge ting that the lack of p53 promotes a higher HO-1 stability. We
plott d the relative amounts of HO-1 levels f r each ES cell line at 7 h of CHX treatment, as
at this time p int we could detect the differences betw en KO and WT ES cells. As shown
n Figure 3b,c, HO-1 protein lev ls gr atly decreas d after CHX treatment in WT ES cells,
while in p53 KO ES cells HO-1 protein levels remained similar to th control condition.
Subsequently, to rul out the ossibility that the observed effect was due to the higher
HO-1 basal levels in p53 KO ES cells, we evaluated the effect of CHX treatm nt in WT cells
pre-tr at d with hemin, a well-known specific HO-1 inducer. The experimental setup of
hemin treatment conditions is shown in Suppleme tary Figure S2a–c. No differences were
detected in HO-1 decay rate when comparing basal HO-1 and hemin-induced HO-1 in WT
ES cells (Supplementary Figure S2d,e). These results indicate that the selected time-points
allowed us to detect HO-1 decay even for high protein levels similar to those observed in
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p53 KO cells, strongly supporting that the effect in p53 KO ES cells described above was
a consequence of a greater HO-1 stability and not due to their higher basal HO-1 levels.
Interestingly, p53 KO ES cells showed similar HO-1 stability when cultured with or without
hemin and such stability was higher in KO than in WT ES cells since 7 h of CHX treatment
are not enough to detect a decrease in HO-1 levels in KO cells (Supplementary Figure S2e).
These results suggest that an unknown mechanism dependent on p53 promotes HO-1
protein degradation in ES cells.
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3.3. p53 KO ES Cells Exhibit Higher HO-1 Cytoplasmic Levels
The stability of multiple proteins is often associated with PTMs and/or interactions
with other proteins that promote or interfere the protein degradation [54,55]. Moreover,
protein subcellular organization is highly modulated and strongly influences regulatory
interactions. Although canonical HO-1 localization is cytoplasmic, this protein was also
reported to localize in the nucleus [56,57]. Thus, we explored HO-1 subcellular distribution
in our experimental system. Cytoplasmic and nuclear HO-1 localization was assessed by
epifluorescence microscopy of HO-1 immunostaining in WT and KO ES cells (Figure 4a).
The quantification of HO-1 distribution revealed that the nuclear-cytoplasmic ratio (N/C
ratio) was lower in KO cells (Figure 4b), indicating a relatively lower proportion of HO-1
in the nucleus in comparison to the cytoplasm. We detected the same pattern of HO-1
localization by confocal microscopy (Supplementary Figure S3). Further research would be
required to explore if HO-1 subcellular localization modulates its stability and whether it is
associated with an altered redox status in ES cells.




Figure 4. p53 KO ES cells exhibit higher HO-1 cytoplasmic levels. Wild type (WT) and p53 KO ES cells were cultured 
under standard conditions and HO-1 protein levels were analyzed by immunofluorescence. (a) Representative fluores-
cence microscopy images of WT and KO ES cells. Scale bars: 10 μm. (b) HO-1 immunofluorescence intensity of nuclei vs. 
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3.4. HO-1 Increases during Differentiation in WT and p53 KO ES Cells 
Based on the evidence that HO-1 is involved in stem cells differentiation [37,58–60], 
we analyzed the HO-1 expression in ES cells during this process. First, we exploited ChIP 
Atlas data-mining platform [61] to investigate histone modifications and the binding of 
multiple transcriptional regulators to Hmox1 locus in undifferentiated ES cells and in ES 
cells subjected to differentiation protocols. The examination of the integrated data showed 
that several proteins associated with transcription repression bind to the Hmox1 regula-
tory region in undifferentiated ES cells (Supplementary Figure S4a), such as EZH2 and 
SUZ12, both components of the Polycomb repressive complex, and MBD3 which binds to 
methylated CpG on DNA, among others. Interestingly, these negative regulators are not 
associated with Hmox1 in ES cells that were induced to differentiate. Furthermore, the 
analysis of histone modifications in undifferentiated ES cells displayed two marks com-
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H3K4. In these cells, we also detected the repressive cytosine modification, 5-methylcyto-
sine (5-mC). Further, trimethylation of H3K4 and acetylation of H3K27, two marks related 
to gene induction, were found in differentiated ES cells (Figure 5a). These results support 
our findings which demonstrate that HO-1 gene expression increases during ES cells dif-
ferentiation (Figure 5b). Based on this evidence, our next purpose was to explore HO-1 
protein levels in p53 KO ES cells during differentiation. For this aim, we studied whether 
HO-1 expression was sensitive to the differentiation signals in a p53 null context. As 
shown in Figure 5b, HO-1 expression was also induced in p53 KO cells along differentia-
tion. 
Additionally, we performed a bioinformatics analysis to evaluate HO-1 expression 
during human ES cells differentiation exploiting publicly available data from high 
throughput microarrays and RNA-sequencing (RNA-seq) experiments. We found that 
HO-1 mRNA levels increase during embryo development (Supplementary Figure S4b) 
and in both non-directed (Figure 5c) and directed (Supplementary Figure S4c) in vitro 
differentiation protocols. Interestingly, p53 shows the opposite behavior as its mRNA lev-
els decrease during differentiation. In parallel, we examined HO-1 expression during re-
programing of human somatic cells into iPS cells. Our analysis showed a significant 
downregulation of HO-1 mRNA levels through this cellular process (Figure 5d). As a 
Figure 4. p53 KO ES cells exhibit higher HO-1 cytoplasmic levels. Wild type (WT) and p53 KO ES cells were cultured
under standard conditions and HO-1 protein levels were analyzed by immunofluorescence. (a) Representative fluorescence
microscopy images of WT and KO ES cells. Scale bars: 10 µm. (b) HO-1 immunofluorescence intensity of nuclei vs.
cytoplasm for WT (blue) or KO (red) ES cells. The equations shown in the figure were obtained by a linear fit of the data,
with a statistical weight corresponding to the number of cells in each field.
3.4. HO-1 Increases duri g Differentiation i WT and p53 KO ES Cells
Based on the evidence that HO-1 is involved in stem cells differentiation [37,58–60],
we analyzed the HO-1 expression in ES cells during this process. First, we exploited ChIP
Atlas data-mining platform [61] to investigate histone modifications and the binding of
multiple transcriptional regulators to Hmox1 locus in undifferentiated ES cells and in ES
cells subjected to differentiation protocols. The examination of the integrated data showed
that several proteins associated with transcription repression bind to the Hmox1 regula-
tory region in undifferentiated ES cells (Supplementary Figure S4a), such as EZH2 and
SUZ12, both components of the Polycomb repressive complex, and MBD3 which binds to
methylated CpG on DNA, among others. Interestingly, these negative regulators are not
associated with Hmox1 in ES cells that were induced to differentiate. Furthermore, the anal-
ysis of histone modificatio s in undifferentiated ES cells displayed two marks commonly
associated with gene repression, trimethylation of H3K27 and methylation of H3K4. In
th se cells, we also detected the repressive cytosine modification, 5-methylcytosine (5-mC).
Furth r, trimethylation of H3K4 and ac tyl tion of H3K27, two m rks related to gene induc-
tion, were found in differentiated ES cells (Figur 5a). These results support our findings
which demonstrate that HO-1 gene expression inc eases d ring ES cells differentiation
(Figure 5b). Based on this evidence, our next purpose was to explore HO-1 protein levels in
p53 KO ES cells during differentiation. For this aim, we studied whether HO-1 expression
was se sit ve to the differ ntiation signals in a p53 null context. As hown in Figure 5b,
HO-1 expression was also induced in p53 KO cells along differentiation.
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Figure 5. HO-1 increases during differentiation in WT and p53 KO ES cells. (a) Analysis of the indicated histone modi-
fications and Cytosine methylation (5-mC) present in Hmox1 locus in undifferentiated ES cells and ES cells subjected to
differentiation protocols (differentiated cells) using the public ChIP-seq data available in Chip Atlas data-mining platform.
Dataset identification numbers of each experiment are shown at the top of the y-axis. (b) WT and KO ES cells were induced
to differentiate by 2i/LIF withdrawal for 2 days (Diff) and HO-1 protein levels were evaluated by Western blot. Upper panels
show representativ blots. GAPDH was used as loading control. Low r panels show HO-1/GAPDH band densitometry
relative to the co trol condition (Un i tiated). Bars re resent the mean ± SEM of three independent experiments. As-
terisks indicate significant differences when compared to the control condition (Undifferentiated) (**, p < 0.01; ***, p < 0.001).
(c) Microarray data analysis of HMOX1 and TP53 gene expression in undifferentiated human ES and in human ES cells
subjected to a non-directed differentiation protocol. (d) Microarray data analysis of HMOX1 and TP53 gene expression
during human fibroblast reprograming into iPS cells. Bars represent the mean ± SEM of each experiment. Asterisks
indicate significant differences between undifferentiated (orange) and differentiated (green) cells (*, p < 0.05; **, p < 0.01;
***, p < 0.001).
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Additionally, we performed a bioinformatics analysis to evaluate HO-1 expression dur-
ing human ES cells differentiation exploiting publicly available data from high throughput
microarrays and RNA-sequencing (RNA-seq) experiments. We found that HO-1 mRNA
levels increase during embryo development (Supplementary Figure S4b) and in both
non-directed (Figure 5c) and directed (Supplementary Figure S4c) in vitro differentiation
protocols. Interestingly, p53 shows the opposite behavior as its mRNA levels decrease
during differentiation. In parallel, we examined HO-1 expression during reprograming of
human somatic cells into iPS cells. Our analysis showed a significant downregulation of
HO-1 mRNA levels through this cellular process (Figure 5d). As a whole, these results high-
light the relevance of HO-1 role during ES cells differentiation and its negative association
with p53.
3.5. HO-1 Is Not Induced in Oxidant Conditions in p53 KO ES Cells Consistent with an Adapted
Stress Response
We reasoned that the lack of p53 and the enhanced HO-1 expression could impact on
the redox balance of the p53 KO ES cell line. To evaluate this scenario, we first investigated
ROS status by measuring their levels with the commonly used H2DCF-DA probe. As
shown in the left panel of Figure 6a, intracellular ROS levels were similar in both cell
lines. Furthermore, we studied ROS levels with two fluorescent redox sensors that feature
higher sensitivity: NpFR1, a flavin molecule that is almost non-fluorescent in its reduced
form and its oxidation gives rise to a 125-fold increase in fluorescence, and NpFR2, a
mitochondrial-targeted fluorescent redox sensor which can reversibly measure changes in
the mitochondrial redox environment [51,52]. While we did not observe any changes using
NpFR2, NpFR1 probe allowed detection of slightly higher cytoplasmic ROS levels in p53
KO cells (Figure 6a, middle and right panels) suggesting a mild difference between cell lines.
Then, we evaluated the effect of H2O2 treatment, commonly used as an oxidant condition,
on HO-1 gene induction and we found that while in WT ES cells HO-1 mRNA levels
increased as expected, they were not modified in KO ES cells (Figure 6b). These results
further evidence an altered response of the cells undergoing oxidative stress conditions.
However, they might also indicate that the cytotoxic effects of H2O2 treatment could be
lower in the p53 KO cell line, probably due to the endogenous higher HO-1 levels observed
in these cells. Finally, to extend our findings, we explored the expression of Superoxide
dismutase 2 (SOD2), a relevant antioxidant enzyme transcriptionally regulated by NRF2
and pluripotency TFs in ES cells [62]. Notably, no differences in Sod2 transcripts were
detected in both ES cell lines; however, its protein levels were boosted in p53 KO ES
cells (Figure 6c), similar to the results found for HO-1. These data suggest that p53 null
phenotype is related to an altered ROS homeostasis in ES cells, which is also associated
with a reinforcement of the antioxidant machinery regulated at the post-translational level.
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Figure 6. HO-1 is not induced in oxidant conditions in p53 KO ES cells consistent with an adapted stress response. WT
and p53 KO ES cells were cultured under standard conditions. (a) ROS levels were measured by flow cytometry with
H2DCF-DA, NpFR2 and NpFR1 probes. Upper panels show representative histograms and lower panels show the relative
fluorescence intensity for each probe. Bars represent the mean ± SEM of three independent experiments. (b) WT and KO ES
cells were treated with 100 µM H2O2 during 4 h and HO-1 mRNA levels were analyzed by RT-qPCR. Bars represent the
mean ± SEM of four independent experiments. (c) Sod2 mRNA and protein levels were analyzed by RT-qPCR and Western
blo , respectively. I RT-qPCR HO-1 or Sod2 levels were normaliz d to the housekeeping ge e Gapdh and referred to the
c rresponding control (untr ated control for (b), WT ES cell lin for (c)). In Western blots GAPDH was used as loading
control. Bars represent the mean ± SEM of three independent experiments. Asterisks indicate significant differences when
comparing to the corresponding control condition (*, p < 0.05).
4. Discussion
The present work demonstrates for the first time, a regulatory crosstalk between
HO-1 and p53 in ES cells. Another remarkable conclusion that emerges from these data is
that HO-1 expression increases during differentiation suggesting an important role of this
protein in stem cells biology. Additionally, the lack of p53 correlates with increased HO-1
protein levels presumably as a cellular mechanism to maintain redox homeostasis. This
study also highlights that p53 modulates HO-1 expression at the post-transcriptional level,
emphasizing the connection between these proteins.
A deep comprehension of the regulation points of gene expression is crucial to un-
derstand the diverse cellular responses. Eukaryotic gene expression involves multiple
exquisitely controlled regulatory layers such as chromatin accessibility, transcription and
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translation rates, RNA processing and RNA and protein stability. Although the main
control point for several genes is at the transcriptional level, diverse post-transcriptional
mechanisms also contribute to gene regulation and cell-specific expression patterns [63].
Growing evidence indicates that ROS function as crucial messengers in cell prolifera-
tion and survival by regulation of gene transcription [64]. Moreover, ROS can also modulate
gene expression at post-transcriptional levels [65–67]. On the other hand, oxidative stress
induces alterations in gene transcription, responding to ROS levels by the activation of a
complex antioxidant defense system [64]. Redox-mediated mitochondria-nucleus crosstalk
coordinates cellular metabolism with chromatin remodeling, gene expression, cell cycle,
DNA repair and cell differentiation [68]. The expression of many components of the stress
defense system is regulated through NRF2 [69]. Additionally, p53 plays a key role in
mechanisms intended to repair ROS-induced damages [70]. Interestingly, during severe
stress conditions, the induction of a very efficient ROS scavenging machinery by the NRF2-
dependent response interferes with the pro-apoptotic response induced by p53. Regarding
p53 pro-oxidant functions, time course experiments demonstrated the existence of a cascade
in which p53 promotes the transcription of redox-controlling genes with the subsequent
cellular ROS enhancement, that leads to mitochondrial oxidative damage and promotes
apoptosis through a three-step process [71]. The balance between the pathways associated
with these TFs determines the cellular fate, which is dependent on the redox status [31].
Particularly, p53 suppresses the NRF2-dependent transcription of genes whose regulator
region contains antioxidant response elements, in several tumoral cell lines [72]. In turn,
NRF2 negatively regulates p53 by promoting MDM2 transcription in murine embryonic
fibroblasts [73].
Particularly in ES cells, redox homeostasis is essential for self-renewal and pluripo-
tency maintenance, and also for proper differentiation. ROS accumulation may cause
apoptosis, premature senescence and unscheduled differentiation [68]. The role of ROS in
regulating stem cell dynamics has implications for various pathologies, including cancer
and age-related diseases, further highlighting that fine regulation of ROS homeostasis
plays an essential role in the fate decision of stem cells from adult tissues [18]. Notably, it
was proposed that p53 regulates stem cells processes by acting as either an antioxidant or a
pro-oxidant in a context-dependent manner. For example, under physiological conditions
or mild oxidative stress, p53 is maintained at low levels by MDM2 mediated proteasomal
degradation [74] and it induces the transcription of antioxidant genes, hence maintaining
low ROS levels [75]. On the other hand, under persistent and severe oxidative stress
conditions, p53 is hyper activated and exerts pro-oxidative activity. In this context, p53
promotes ES cells differentiation and certain pathways that safeguard DNA fidelity, thus
preserving their genome integrity and avoiding the propagation of genetic aberrations to
daughter cells [24,76]. Beyond ROS modulation by p53, this TF has a wide range of actions
in stem cells. Genomic stability maintenance, induction of differentiation and regulation of
metabolism are some examples of p53 functions [77]. Furthermore, unveiling p53 roles in
pluripotent stem cells will contribute to the development of safe stem cells-based therapies.
Regarding the defense against oxidative damage, there is compelling evidence that
propose HO-1 induction as an important cytoprotective mechanism and some authors
explored HO-1 stability modulation. Hwang et al. showed that HO-1 forms dimers and
oligomers in the ER and this interaction results in its stabilization [78]. The ubiquitina-
tion also plays a role in its stability, probably involved in its ER-associated proteasomal
degradation [79]. A recent work demonstrates that 14-3-3ζ, a protein implicated in the
initiation and progression of multiple types of cancer, interacts with HO-1 and regulates its
stability by inhibiting its ubiquitination [80]. It is interesting to mention that there are not
previous reports about regulators of HO-1 stability in ES cells. Our results showed that
p53 KO ES cells have higher HO-1 protein levels compared to WT cells; however, similar
levels of NRF2 and pS40 NRF2 were found in both cell lines, consistent with the outcome
that no differences were detected in HO-1 mRNA levels. These findings along with the
increased stability of HO-1 in KO cells revealed by CHX treatment, lead us to speculate
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that a negative post-transcriptional mechanism exerted by p53 is involved in HO-1 stability
modulation, suggesting a new role for this protein in the antioxidant system of ES cells.
Work by us [56] and others [81] reported the localization of HO-1 in the nucleus
of cancer cells, where it is suggested to mediate signaling functions. Even more, this
localization may be associated with certain stress conditions like oxidative stress [57]. To
our best knowledge, herein, for the first time, we report HO-1 nuclear localization in both
WT and p53 KO ES cells lines. This is an interesting finding that encourages us to focus
future work in exploring a putative HO-1 nuclear function in ES cells. Interestingly, p53
KO ES cells present slightly but significantly lower N/C ratio than WT ES cells, suggesting
higher HO-1 cytoplasmic levels in the absence of p53. We hypothesize that this could
be a compensatory mechanism due to the lack of p53, that could contribute to cellular
homeostasis maintenance. As we mentioned before, HO-1 canonical activity takes place in
the cytoplasm. Therefore, HO-1 higher levels in the cytoplasm of p53 KO ES cells could
be responsible for the maintenance of redox balance. This idea is consistent with the fact
that p53 KO ES cells have almost unaltered ROS levels and with the absence of HO-1
induction after H2O2 treatment in these cells. Finally, we detected that the regulation
of the Sod2 gene follows the same expression pattern as HO-1, since Sod2 mRNA levels
are similar between both cell lines but KO ES cells display higher SOD2 protein levels.
This interesting observation suggests that p53 might also control the expression of other
relevant antioxidant proteins at the post-transcriptional level. Future studies will be
necessary to reveal a putative common p53-mediated mechanism involved in protein
stability modulation, particularly of those participating in the antioxidant defense system.
Regarding p53 and HO-1 gene regulation, Nam et al. showed that specifically under
oxidative stress, but not under DNA damage-associated stress, p53 promotes cell survival
by induction of Hmox1 transcription [29]. In line with this report, we found that HO-1
gene is induced by H2O2 treatment only in WT ES cells. Remarkably, no Hmox1 induction
was observed in p53 KO ES cells, due to the lack of p53 and in accordance with Nam
et al. findings in mouse embryonic fibroblasts and in human colon carcinoma cells [29].
However, we cannot rule out that these cells are insensitive to H2O2 treatment due to their
high endogenous HO-1 levels. We propose that these basal levels would be a consequence
of compensatory cellular mechanisms triggered by the high oxidative stress, which boosted
HO-1 levels counteracting altered redox homeostasis.
In addition, during ES cells differentiation both HO-1 [37,58,60,82–84] and p53 [24,76,
82,85] play a relevant role. Using the Chip Atlas platform, we found that in undifferentiated
ES cells Hmox1 is associated with negative transcriptional regulators. Further, we found
histone modifications known to be associated with gene repression in undifferentiated
ES cells. Moreover, in differentiation-inducing conditions, histone marks related to gene
activation were revealed. These observations are consistent with our results that show the
increment of HO-1 during the differentiation process. Furthermore, analysis of microarray
and RNA-seq experiments from publicly available data bases allowed us to analyze HO-1
expression during both direct and non-direct differentiation protocols. Using data from non-
directed and lineage-specific differentiation protocols we revealed that HO-1 is modulated
during diverse differentiation processes. Interestingly, despite its higher basal levels, HO-
1 also increases during differentiation in p53 KO ES cells. The fact that HO-1 gene is
induced during differentiation, contrary to some other antioxidant proteins like SOD2,
which expression decreases during this process, highlights the notion that besides being
involved in cell stress defense, HO-1 could be a relevant protein for ES cells differentiation.
To conclude, in this work we report a regulatory relationship between two main
components of different cellular defense systems in ES cells, opening new perspectives
to delve into the complex mechanisms involved in ROS balance that are crucial for the
maintenance of stem cells’ fundamental properties and for their differentiation.
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